Advertisement
| epinastine hydrochloride ophthalmic solution: Handbook of Emergency Ophthalmology Brit Long, Alex Koyfman, 2018-06-21 This book provides emergency physicians with an easy-to-use guide for diagnosing and treating ophthalmologic conditions in the emergency department. Ophthalmologic complaints are very common, but many emergency physicians are not as confident as they would like to be when evaluating and managing these conditions. This book answers that need by giving step-by-step instructions on how to diagnose and treat common eye conditions, including glaucoma, infections, neuro-ophthalmologic conditions, and trauma. For each disorder, the book discusses presentation/symptoms, physical examination techniques, lab and imaging findings, differential diagnoses, treatment guidelines, and referral suggestions. The text is filled with images that clearly present these common ophthalmologic complaints and conditions and guide the emergency physician to an accurate and swift diagnosis. Handbook of Emergency Ophthalmology is an essential resource for emergency physicians, residents, medical students, nurses, and other healthcare workers who evaluate and manage patients with ophthalmologic conditions. |
| epinastine hydrochloride ophthalmic solution: Advanced Concepts in Human Immunology: Prospects for Disease Control Pooja Jain, Lishomwa C. Ndhlovu, 2020-08-11 This book highlights information derived primarily from clinical samples, with particular reference to theoretical and scientific aspects of the human immune system. This text will focus on topics that range from host-pathogen interactions in infectious disease to host immune response in cancer, allergic diseases, neuroinflammatory diseases, and autoimmune disorders. The reader will also have a well-rounded understanding of the behavior of the immune system with particular emphasis on the role of immunoproteomics in immunotherapy, neuroprotective immunity for neurodegenerative and neuroinfectious disease, leukemia-associated dendritic cell induction of adaptive immunity dysregulation, and the role of immune checkpoint inhibitors in cancer, infection, as well as neuroinflammation. Taken together, the contents of this book are intended for both clinicians and researchers in academia and industry. |
| epinastine hydrochloride ophthalmic solution: Hale's Medications & Mothers' MilkTM 2019 Thomas W. Hale, RPh, PhD, 2018-05-28 Praise for Earlier Editions: “[This] is our gold standard.” --Sandra J. Cole, RNC, IBCLC Sharp Mary Birch Hospital, San Diego, CA “I am both a clinical instructor in maternal/child and IBCLC. I haven't used Briggs since Hale came along.” --Barbara Hotelling, MSN WHNP LCCE CD(DONA) CHT IBCLC Duke University Medical Center Written by a world-renowned expert in perinatal pharmacology, this essential reference contains current, complete, and evidence-based information on the transmission of maternal drugs into human milk. Because so many women ingest medications while breastfeeding, one of the most common questions encountered in pediatrics is: Which drugs are safe and which are hazardous for the infant? This 2019 edition has been extensively revised, and now includes 39 completely new and 331 updated medications, and state-of-the-art coverage of multiple diseases, vaccines, and syndromes. It addresses the use of radiopharmaceuticals, chemotherapeutic agents, and vaccines in breastfeeding mothers, and covers adult concerns, methods of reducing risk to infants, and infant monitoring. New to the 2019 Edition: An updated design for easier access to information Drug names in running heads for easier reference The latest information on the impact of prescription medications, over-the-counter drugs, herbs, and street drugs Updates to existing drug monographs Key Features: Evidence-based, current information on over 1300 drugs, diseases, vaccines and syndromes Dr. Hale’s renowned “Lactation Risk Categories” Adult concerns, adult dose, pediatric concerns, infant monitoring, and alternatives Key points and savvy tips about breastfeeding and medications for quick reference Succinct information about evaluation of the infant Common abbreviations and drugs listed in alphabetical order |
| epinastine hydrochloride ophthalmic solution: Hale's Medications & Mothers' MilkTM 2021 Thomas W. Hale, RPh, PhD, 2020-07-14 Note to Readers: Publisher does not guarantee quality or access to any included digital components if book is purchased through a third-party seller. Written by a world-renowned expert in perinatal pharmacology, this essential reference contains current, complete, and evidence-based information on the transmission of maternal drugs into human milk. Because so many women ingest medications while breastfeeding, one of the most common questions encountered in pediatrics is: Which drugs are safe and which are hazardous for the infant? This 2021 edition has been extensively revised, and now includes 50 completely new and 356 updated medications, and state-of-the-art coverage of multiple diseases, vaccines, and syndromes. It addresses the use of radiopharmaceuticals, chemotherapeutic agents, and vaccines in breastfeeding mothers, and covers adult concerns, methods of reducing risk to infants, and infant monitoring. New to the 2021 Edition: 50 New Drugs Added 356 Drugs Updated with new data 817 Drug References Updated An updated 7x10 trim size and streamlined design for ease of use in patient education The latest information on the impact of prescription medications, over-the-counter drugs, herbs, and street drugs Key Features: Evidence-based, current information on over 1300 drugs, diseases, vaccines, and syndromes Dr. Hale's renowned Lactation Risk Categories incorporate recent updates Key points and savvy tips about breastfeeding and medications for quick reference Common abbreviations and drugs listed in alphabetical order Adult concerns, adult dose, pediatric concerns, infant monitoring, and alternatives Succinct information on evaluation of the infant Subscribe to www.springerpub.com/haleand experience all the benefits of using Hale's Medications and Mothers Milk online and on mobile devices! Go to www.springerpub.com/haleto learn more and subscribe today! |
| epinastine hydrochloride ophthalmic solution: Plumb's Veterinary Drug Handbook James A. Budde, Dawn M. McCluskey, 2023-05-31 Plumb’sTM VETERINARY DRUG HANDBOOK Find drug dosages and other critical information for prescribing drugs to animals quickly and efficiently in this fully updated new edition of this must-have veterinary resource The Tenth Edition of Plumb’s® Veterinary Drug Handbook updates the most comprehensive, detailed, and trusted source of drug information relevant to veterinary medicine. Covering dosages, drug interactions, adverse effects, and contraindications, among other key drug details, this bestselling book is a must for practicing veterinarians and anyone requiring reliable information on the use of drugs in animals. Designed for ease of use, the book surveys an exhaustive list of drugs with applications for a wide variety of species, including dogs, cats, birds, small mammals, and farm animals. This edition includes updates to all 738 drug monographs and adds 30 new monographs, including 9 new insulin monographs, to its exhaustive coverage of drugs used in the care of animals. This new edition: Provides an extensively reviewed and updated version of the must-have veterinary drug reference Includes 30 new drug monographs, including 9 new insulin monographs Updates all 738 drug monographs, with robust citing of new information Covers a wide variety of species, including dogs, cats, birds, small mammals, and farm animals Presents detailed dosing information for an exhaustive list of drugs used in animals Plumb’s® exhaustive coverage of drugs relevant to the veterinary field makes this book an essential reference for veterinarians, veterinary technicians, veterinary pharmacologists, pharmacists with veterinary patients, and libraries that serve these groups. |
| epinastine hydrochloride ophthalmic solution: Recent Developments in Anti-Inflammatory Therapy Parteek Prasher, Flavia Zacconi, Kamal Dua, Michael Rathbone, Jeffrey Withey, 2023-02-17 Advances in Anti-inflammatory Therapy explores the cutting-edge in anti-inflammation therapy in clear and concise language, with insights from academia and industry. Sections cover key regulatory pathways that mediate acute and chronic inflammation and disease onset. Further chapters are devoted to advanced anti-inflammatory pharmaceuticals, including chemical moieties, pharmacophores, APIs, natural products, herbal therapies, molecular nanomedicine and advanced drug delivery vectors. Systematically planned chapters and illustrations enable potential readers to gain essential insights on the most recent advancements in the field. Arranged with systematic chapters covering a broad range of inflammatory diseases, discussions on past, current and future therapeutics and advanced anti-inflammatory pharmaceuticals, this book will be useful to a wide range of researchers, especially medicinal chemists, drug design experts, and biological and translational researchers working in the field of inflammation. - Identifies recent developments and current trends in anti-inflammation therapy - Discusses advanced chemotherapeutics, SAR analysis of novel pharmacophores and natural products - Outlines the pathophysiology of inflammatory pathways in the pathogenesis of disease onset, including strategies to counter these intricacies - Contains a blend of editors from both academia and industry |
| epinastine hydrochloride ophthalmic solution: Ocular Allergy Leonard Bielory, 2008 Topics include: Introduction- Immunopathophysiology and Classification of Ocular Allergy, OcularMast CDermatologicdisorders of the Eyelidsells and Mediators,SeasonalAllergic Conjunctivitis&Perennial Allergic Conjunctivitis,VernalKeratoconjunctivitis,GiantPapillary Conjunctivitis,Dermatologicdisorders of the Eyelids,ContactDermatitis of the Eyelids,AutoimmuneDisorders of the Anterior Surface,PediatricConcerns of Ocular Inflammation,ContactLens,OcularAllergy Treatment,Adverse(Allergic) Effects of GlaucomaMedications |
| epinastine hydrochloride ophthalmic solution: Handbook of Pharmaceutical Manufacturing Formulations, Third Edition Sarfaraz K. Niazi, 2019-12-09 The Handbook of Pharmaceutical Manufacturing Formulations, Third Edition: Volume Six, Sterile Products is an authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this sixth volume of a six-volume set, compiles data from FDA and EMA new drug applications, patents and patent applications, and other sources of generic and proprietary formulations including author’s own experience, to cover the broad spectrum of cGMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent. Features: Largest source of authoritative and practical formulations, cGMP compliance guidance and self-audit suggestions Differs from other publications on formulation science in that it focuses on readily scalable commercial formulations that can be adopted for cGMP manufacturing Tackles common difficulties in formulating drugs and presents details on stability testing, bioequivalence testing, and full compliance with drug product safety elements Written by a well-recognized authority on drug and dosage form development including biological drugs and alternative medicines |
| epinastine hydrochloride ophthalmic solution: Ocular Surface Disease: Cornea, Conjunctiva and Tear Film Edward J Holland, Mark J Mannis, W. Barry Lee, 2013-05-17 Ocular Surface Disease: Cornea, Conjunctiva and Tear Film incorporates current research and the latest management strategies as well as classification systems and treatment paradigms for all forms of ocular surface disease. This is the first comprehensive resource that helps you to meet ocular surface disease challenges effectively using today's best medical and surgical approaches. Get the complete, evidence-based guidance you need to provide optimal care for your patients with ocular surface disease. Implement the latest drug treatments and surgical interventions to provide better outcomes with fewer complications. Hone and expand your surgical skills by watching videos of leading experts performing advanced procedures including ocular surface transplantation techniques; amniotic membrane transplantation; pterygium surgery; lamellar keratoplasty (DALK) in ocular surface disease; and keratoprosthesis surgery. Visualize how to proceed by reviewing detailed, full-color images and consulting new classification systems and treatment paradigms for mild to severe forms of ocular surface disease. Take it with you anywhere! Access the full text, downloadable image library, video clips, and more online at expertconsult.com. |
| epinastine hydrochloride ophthalmic solution: Handbook of Pharmaceutical Manufacturing Formulations Safaraz K. Niazi, 2016-04-19 No other area of regulatory compliance receives more attention and scrutiny by regulatory authorities than the regulation of sterile products, for obvious reasons. With the increasing number of potent products, particularly the new line of small protein products, joining the long list of proven sterile products, the technology of manufacturing ster |
| epinastine hydrochloride ophthalmic solution: PDR for Ophthalmic Medicines , 2007 This essential reference guide for eye-care professionals contains information on the drugs and equipment used in the fast-changing ophthalmology and optometry fields. The detailed encyclopedia is enhanced by color product photographs and information on all types of contact lenses and specialized instruments. |
| epinastine hydrochloride ophthalmic solution: Ophthalmic Product Development Seshadri Neervannan, Uday B. Kompella, 2022-03-11 This is a comprehensive textbook addressing the unique aspects of drug development for ophthalmic use. Beginning with a perspective on anatomy and physiology of the eye, the book provides a critical appraisal of principles that underlie ocular drug product development. The coverage encompasses topical and intraocular formulations, small molecules and biologics (including protein and gene therapies), conventional formulations (including solutions, suspensions, and emulsions), novel formulations (including nanoparticles, microparticles, and hydrogels), devices, and specialty products. Critical elements such as pharmacokinetics, influence of formulation technologies and ingredients, as well as impact of disease conditions on products development are addressed. Products intended for both the front and the back of the eye are discussed with an eye towards future advances. @font-face {font-family:Cambria Math; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:3 0 0 0 1 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1073732485 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:Times New Roman,serif; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:Calibri,sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:Times New Roman; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-US; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} |
| epinastine hydrochloride ophthalmic solution: Hale’s Medications & Mothers’ Milk 2023 Thomas W. Hale, PhD, Kaytlin Krutsch, PharmD, MBA, BCPS, 2022-05-23 The worldwide gold standard for lactation support professionals Developed by world leaders in lactational pharmacology, this essential reference contains the most current, complete, and evidence-based information available on the transmission of maternal drugs into human milk. It thoroughly addresses one of the most commonly asked questions by breastfeeding mothers—which drugs are safe, and which are hazardous for the infant? The new twentieth edition adds 72 new drugs, updates 356 medications with new data, and adds new information to 927 drugs. The resource relies upon the most current evidence-based studies to evaluate the relative risk of commonly used drugs including Dr. Hale's highly renowned Lactation Risk Categories (LRC). Considered indispensable by hundreds of clinicians worldwide, the book lists safe alternatives for drugs one is currently taking or might need to take in the future. For ease of access to information, it includes key points and savvy tips in information boxes, common abbreviations, illustrative diagrams, concise information on evaluating the infant, and more. New to the 2023 Edition: 72 new drugs 356 medications updated with new data 3 drugs with FDA updates 927 medications updated with new information 74 existing drugs with updated LRC NEW TABLES on monoclonal antibodies and migraines New information on Cannabis. Key Features: Delivers current, evidence-based information on over 1300 drugs, diseases, vaccines, syndromes Incorporates recent updates to Dr. Hale's world-renowned LRC Includes key points and savvy tips about breastfeeding and medications for quick reference Lists common abbreviations and drugs in easily-accessible alphabetical order Discusses adult concerns, adult dose, pediatric concerns, infant monitoring, and alternatives Includes succinct information on evaluation of the infant |
| epinastine hydrochloride ophthalmic solution: Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics Sunny Ohia, Najam Sharif, 2022-07-26 Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics provides a review of the basic anatomy, physiology, biochemistry and pathology of the eye with a focus drug therapy, drug delivery and use of therapeutic medical miniature devices. An understanding of the pharmacological actions of drugs acting on the eye requires the student and health care practitioner to learn additional principles in basic and clinical sciences that are unique to this organ. As a sensory organ, the eye is relatively inaccessible to the systemic circulation due to the blood-vitreous, blood-aqueous and blood-retinal barriers. Consequently, the administration of drugs for therapeutic effects in the eye necessitates an understanding of physico-chemical properties of the molecules and pharmacokinetic principles involved in the access to its site of action via topical, intracameral and intravitreal administration. This book includes information on the general principles of pharmacokinetics and pharmacodynamics of drugs as it pertains to the eye and in combating ocular disorders and diseases. Using a disease-themed approach, the book discusses basic and clinical pharmacological principles involved in the therapy of these diseases including the ocular side effect of systemically-administered drugs, drugs used in ophthalmic surgery and miscellaneous agents, the therapeutic utility of biologics, drug conjugates, combination products, gene and cellular therapy are also covered. Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics is useful as a primary and secondary source of reference for up-to-date information about the pharmacological mechanisms of action, pharmacokinetics, side effects, drug-drug interactions and therapeutic indications of drugs for pharmacologists, pharmaceutical scientists, students in the health care disciplines (nursing, pharmacy, optometry, medical), and practitioners in optometry and ophthalmology. - Explains the mechanisms of action, side-effects and therapeutic uses of drugs, biologics, miniature devices, gene and cellular therapies for the eye - Provides a comprehensive review of the anatomy, physiology, biochemistry, pharmacology, microbiology, genetics and pathology of parts of the eye involved in drug therapy to combat eye disorders and diseases - Explores the pharmacological and clinical basis of drugs, drug conjugates, combination products used in the treatment of anterior and posterior segment diseases |
| epinastine hydrochloride ophthalmic solution: Hale’s Medications & Mothers’ Milk 2025-2026 Thomas W. Hale, RPh, PhD, Kaytlin Krutsch, PhD, PharmD, MBA, BCPS, 2024-08-15 The peerless resource that lactation consultants consult and trust! Filled with authoritative, current, and evidence-based information, the 2025-2026 edition of this internationally renowned drug reference remains the gold standard on the safe use of medications in breastfeeding mothers. Extensively updated throughout, the 2025-2026 edition encompasses numerous new and updated drugs and delivers current knowledge on relevant diseases, vaccines, and syndromes as they impact infant risk. Written by world-renowned clinical pharmacologists, the highly detailed manual relies on the most current evidence-based studies to evaluate the relative risk of commonly used drugs. It is precisely organized for quick information retrieval and features the respected guidance of Dr. Hale's Lactation Risk Categories (LRC), listing safe alternatives for drugs one is currently taking or might need to take in the future. For ease of access to information, the reference highlights key points and savvy tips and presents common abbreviations, illustrative diagrams, concise information on evaluating the infant, and more. New to the 2025-2026 Edition: 66 New drugs 338 medications updated with new data 10 drugs with FDA updates 575 medications updated with new information 84 existing drugs with updated LRC Key Features: Delivers current, evidence-based information on over 1,300 drugs, diseases, vaccines, and syndromes Includes key points and savvy tips about breastfeeding and medications for quick reference Incorporates recent updates to Dr. Hale's world renowned Lactation Risk Categories (LRC) Provides critical updates on weight loss drugs such as Wegovy and Ozempic, heart failure drugs such as Entresto, medications for anxiety, postpartum depression, and much more. Lists common abbreviations and drugs in easily accessible alphabetical order Discusses adult concerns, adult dose, pediatric concerns, infant monitoring, and drug alternatives |
| epinastine hydrochloride ophthalmic solution: Nanotechnology in Ophthalmology Mahendra Rai, Marcelo Luis Occhiutto, Sushama Talegaonkar, 2023-07-18 **Selected for Doody's Core Titles® 2024 in Ophthalmology**Nanotechnology in Ophthalmology is a comprehensive and up-to-date reference on the role and applications of nanotechnology in ophthalmology, from drug delivery and treatment of ocular diseases to toxicity issues. Written by experts from the nanotechnology, ophthalmology, and pharmacology fields, this book has a unique, broad and diverse scope, including chapters on nanosensor-based diagnostic tools, delivery of nanobiomaterials, implantable materials and devices, delivery of nanobiomaterials, nanotechnology for medical and surgical treatment, regenerative medicine, and more. This book provides a valuable reference to researchers working in the areas of ophthalmology, nanoscience and pharmacology, and clinical fellows who are interested in nanoophthalmology as a reference for their practice and research. - Provides a comprehensive review of the literature in the area of nanoophthalmology - Discusses regenerative medicine, drug delivery, imaging, and medical device applications - Analyzes treatment strategies for emerging and multidrug-resistant ocular pathogens |
| epinastine hydrochloride ophthalmic solution: AHFS Drug Information Gerald K. McEvoy, 2005 |
| epinastine hydrochloride ophthalmic solution: Frontiers in Clinical Drug Research - Anti-Allergy Agents Atta-ur-Rahman, 2018-07-11 Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The third volume of this series brings 5 reviews which cover the following topics: H1 receptor selectivity, chronic spontaneous urticaria therapy, smooth muscle cell Ca2+ signaling pathway targeting for asthma therapy, allergic rhinitis and endosomal toll-like receptors. Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field. |
| epinastine hydrochloride ophthalmic solution: Drugs for Pregnant and Lactating Women E-Book Carl P. Weiner, 2018-10-17 Logically organized and easy to use, Drugs for Pregnant and Lactating Women, 3rd Edition, is your #1 resource for details on how virtually all of today's drugs and herbal supplements interact with pregnancy and lactation. More than just a dosing manual, this unique title by Dr. Carl P. Weiner fully explains whether each drug is FDA-approved for use by expecting or nursing mothers, is known to be safe for use, or is known to pose a danger. With up-to-date coverage of nearly 2,000 substances, it provides the thorough details you need to choose the most effective course of treatment. - Uses a consistent, easy-to-follow format for each substance: generic and trade name • class • indications • mechanism of action • dosage, with contraindications and cautions • maternal considerations • fetal considerations • drug interactions • breastfeeding safety • references • and summary information. - Describes over-the-counter drugs and alternative medications as well as prescription drugs. - Uses an eye-catching icon to highlight known teratogens. - Includes international drug names to give this reference a global perspective. - Features new letter thumb tabs for easier navigation. - Includes dozens of new drugs and thorough updates throughout. - Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, images, videos (including video updates), glossary, and references from the book on a variety of devices. |
| epinastine hydrochloride ophthalmic solution: Principles and Practice of Ophthalmology E-Book Daniel M. Albert, Joan W. Miller, Dimitri T. Azar, Barbara A. Blodi, 2008-02-27 Inside the 3rd edition of this esteemed masterwork, hundreds of the most distinguished authorities from around the world provide today's best answers to every question that arises in your practice. They deliver in-depth guidance on new diagnostic approaches, operative technique, and treatment option, as well as cogent explanations of every new scientific concept and its clinical importance. With its new streamlined, more user-friendly, full-color format, this 3rd edition makes reference much faster, easier, and more versatile. More than ever, it's the source you need to efficiently and confidently overcome any clinical challenge you may face. Comprehensive, authoritative, and richly illustrated coverage of every scientific and clinical principle in ophthalmology ensures that you will always be able to find the guidance you need to diagnose and manage your patients' ocular problems and meet today's standards of care. Updates include completely new sections on Refractive Surgery and Ethics and Professionalism... an updated and expanded Geneitcs section... an updated Retina section featuring OCT imaging and new drug therapies for macular degeneration... and many other important new developments that affect your patient care. A streamlined format and a new, more user-friendly full-color design - with many at-a-glance summary tables, algorithms, boxes, diagrams, and thousands of phenomenal color illustrations - allows you to locate the assistance you need more rapidly than ever. |
| epinastine hydrochloride ophthalmic solution: Medications and Mothers' Milk 2017 Thomas W. Hale, RPh, PhD, Hilary E. Rowe, PharmD, 2016-10-24 Now in its 17th Edition, Medications and Mothers’ Milk, is the worldwide best selling drug reference on the use of medications in breastfeeding mothers. This book provides you with the most current, complete, and easy-to-read information on thousands of medications in breastfeeding mothers. This massive update has numerous new drugs, diseases, vaccines, and syndromes. It also contains new tables, and changes to hundreds of existing drugs. Written by a world-renown clinical pharmacologist, Dr. Thomas Hale, and Clinical Pharmacy Specialist Dr. Hilary Rowe, this drug reference provides the most comprehensive review of the data available regarding the transfer of various medications into human milk. This new and expanded reference has data on 1,115 drugs, vaccines, and herbals, with many other drugs and substances included in the appendices. New to this Edition: Many new drugs, vaccines, herbals, and chemicals. Major updates to existing drug monographs. New tables to compare and contrast the suitability of psychiatric medications. New table to compare and contrast pain medications. Updated table and new monograph on hormonal contraception. If you work with breastfeeding mothers, this book is an essential tool to use in your practice. |
| epinastine hydrochloride ophthalmic solution: Roy and Fraunfelder's Current Ocular Therapy Frederick Hampton Roy, Frederick W. Fraunfelder, Frederick T. Fraunfelder, 2008-01-01 This book is designed to be concise with a consistent format so that the clinician can focus on a specific area. This edition has had major modifications and embraces evidence-based medicine. The format includes the CPT codes for billing purposes, short description of the condition, etiology/incidence, course/prognosis, laboratory findings, differential diagnosis; prophylaxis, treatment (local and systemic, surgical or other), miscellaneous (names and addresses of support groups) and key references. Incorporates evidence-based medicine so you feel confident that you're formulating the best treatment plans for your patients.Color photos allow you to read about and actually see a picture of select disease entities.Clear, concise format can be photocopied and distributed to patients in some cases, reducing your time spent explaining problems to patients and caregivers. |
| epinastine hydrochloride ophthalmic solution: Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 9th edition Judith E. Tintinalli, O. John Ma, Donald Yealy, Garth D. Meckler, J. Stephan Stapczynski, David M. Cline, Stephen H. Thomas, 2019-10-22 Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. The long-awaited new edition of the world's most widely used and highly regarded textbook and reference of emergency medicine A Doody's Core Title for 2019! Tintinalli’s Emergency Medicine is THE essential resource for everyone working in, and teaching emergency medicine. The Ninth Edition provides the depth and breadth of coverage that reflects the complexity and expertise needed to practice emergency medicine in today’s fast-paced environments. This comprehensive text is an important clinical resource for physicians, residents and students, advance practice providers, emergency nurses, EMTs, and paramedics. It is a necessary resource for in-training and board examinations, and recertification. Tintinalli’s Emergency Medicine covers everything from prehospital care, disaster preparedness, and basic and advanced resuscitative techniques, to all the significant medical, traumatic, and environmental conditions requiring emergency treatment in adults, children and neonates. Highlights of the Ninth Edition: • Full-color design with more tables than ever to succinctly present key information • Extensive updates to all sections, incorporating the latest clinical and evidence-based information • Online access to over 100 videos, covering a wide range of diagnostic and therapeutic procedures, and POCUS for obstetric/gynecologic, pediatric, musculoskeletal, and vascular conditions • World-class pediatric section on the care of neonates, infants, and children • Expanded chapters on the management of gynecologic and obstetric conditions and emergencies • Updated information on toxicologic and environmental emergencies • Contemporary, concise discussion of ED identification and treatment of opioid use disorders • Updated information on procedural sedation • Expert advice on the management and care of transgender patients • Latest information available on neurologic and cardiac emergencies From the reviews of the seventh edition: Collectively, they have once again produced an excellent text that manages to cover the broad scope of emergency medicine while remaining an easily readable and practical resource....Last, for the inevitable comparison of this current edition of Tintinalli's Emergency Medicine with other available emergency medicine textbooks available: in my opinion, Tintinalli’s still comes out on top. It is more concise and easier to read than some, yet it covers the breadth of emergency medicine practice more comprehensively than others....Just as previous editions did, the seventh presents all of the most pertinent and up-to-date information in a well-organized format that is comprehensive yet easy to read. That and many of the attractive new features in this current edition will ensure its place on my bookshelf for years to come.―JAMA |
| epinastine hydrochloride ophthalmic solution: Harwood-Nuss' Clinical Practice of Emergency Medicine Allan B. Wolfson, Robert L. Cloutier, Gregory W. Hendey, Louis J. Ling, Jeffrey J. Schaider, Carlo L. Rosen, 2014-10-27 Harwood-Nuss' Clinical Practice of Emergency Medicine presents a clinically focused and evidence-based summary of emergency medicine. Chapters are templated to include the clinical presentation, differential diagnosis, evaluation, management and disposition, with highlighted critical interventions and common pitfalls. Management and disposition are especially critical in the emergency department, and their emphasis is unique to Harwood-Nuss. Often, a diagnosis can not be made, given the constraints of an ED evaluation; thus, effecive management of the patient, with or without a confirmed diagnosis, is key. Also distinct to Harwood-Nuss is the High-Risk Chief Complaints section, which covers the key presentations in the ED: chest pain, abdominal pain, shortness of breath, altered mental status. When patients present in the ED, they don't present with a known diagnosis; this chapter walks the physician through possible differential diagnoses and the evaluation and management of these patients so that they can be stabilized and treated quickly and effectively. |
| epinastine hydrochloride ophthalmic solution: The Textbook of Pharmaceutical Medicine John P. Griffin, 2009-10-15 The Textbook of Pharmaceutical Medicine is a standardreference for all those working in pharmaceutical medicine and therecognised text for the UK Faculty of Pharmaceutical MedicineDiploma. This is a comprehensive volume covering the processes bywhich medicines are developed, tested and approved. Regulations fordrug development in the UK, EU, USA, Australia and Japan arediscussed, providing relevant information for drug approval in themain continents where new drugs are developed. The chapters are written by leading academics, medical directorsand lawyers, providing authoritative and in-depth information fortrainees on the Faculty course, and for physicians working in thepharmaceutical industry. As well as thorough updating of theregulatory chapters, the 6th edition includes chapters onthese vital new areas: Paediatric regulation Ethics Due diligence and the pharmaceutical physician |
| epinastine hydrochloride ophthalmic solution: Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 31st Edition (2011) Food and Drug Administration, 2011 FDA Orange Book 31st Edition - 2011 (Approved Drug Products With Therapeutic Equivalence Evaluations) |
| epinastine hydrochloride ophthalmic solution: KAZANO Drug Profile, 2023 DrugPatentWatch, 2023-08-15 <h2>KAZANO Drug Profile, 2023</h2> <p>This report focuses on KAZANO and covers the following critical aspects of this drug:</p> <ul><li>United States patents</li> <li>Expired United States patents</li> <li>FDA Paragraph IV patent challenges</li> <li>District Court patent litigation</li> <li>European supplementary protection certificates (SPCs)</li> <li>Clinical trials</li> <li>Drug prices</li> <li>Finished product suppliers</li> </ul> |
| epinastine hydrochloride ophthalmic solution: Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 8th edition Judith E. Tintinalli, J. Stephan Stapczynski, O. John Ma, David M. Cline, Garth D. Meckler, 2016-03-22 The most widely used and highly regarded textbook and reference of emergency medicine -- Endorsed by the American College of Emergency Physicians The 8th edition of Tintinalli’s Emergency Medicine provides the depth and breadth of coverage that reflects the complexity and expertise needed to practice emergency medicine successfully in today’s fast–paced environments. It is an important contemporary clinical emergency care resource for physicians, NPs, and PAs who practice emergency medicine and for emergency medicine and pediatric emergency medicine fellows. It remains the preferred study guide for in-training and board examinations and recertification. NEW to this edition: • Full-color design with more tables than ever to succinctly present key information • Extensive updates to all sections, incorporating the latest guidelines, evidence-based protocols, and relevant research • Expanded pediatric section, with complete clinical information for general and pediatric emergency physicians • Expanded coverage of common emergency department procedures, with improved illustrations • Online access to more than 30 videos, covering a wide range of procedural and diagnostic topics and focusing on the latest ultrasound-guided techniques From the reviews of the seventh edition: Collectively, they have once again produced an excellent text that manages to cover the broad scope of emergency medicine while remaining an easily readable and practical resource....Last, for the inevitable comparison of this current edition of Tintinalli's Emergency Medicine with other available emergency medicine textbooks available: in my opinion, Tintinalli’s still comes out on top. It is more concise and easier to read than some, yet it covers the breadth of emergency medicine practice more comprehensively than others....Just as previous editions did, the seventh presents all of the most pertinent and up-to-date information in a well-organized format that is comprehensive yet easy to read. That and many of the attractive new features in this current edition will ensure its place on my bookshelf for years to come.—JAMA |
| epinastine hydrochloride ophthalmic solution: Approved Drug Products with Therapeutic Equivalence Evaluations , 2005 |
| epinastine hydrochloride ophthalmic solution: Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 32nd Edition (2012) Food and Drug Administration, 2012 FDA Orange Book 32nd Edition - 2012 (Approved Drug Products With Therapeutic Equivalence Evaluations) |
| epinastine hydrochloride ophthalmic solution: Allergy Frontiers:Clinical Manifestations Ruby Pawankar, Stephen T. Holgate, Lanny J. Rosenwasser, 2009-03-15 When I entered the field of allergy in the early 1970s, the standard textbook was a few hundred pages, and the specialty was so compact that texts were often authored entirely by a single individual and were never larger than one volume. Compare this with Allergy Frontiers: Epigenetics, Allergens, and Risk Factors, the present s- volume text with well over 150 contributors from throughout the world. This book captures the explosive growth of our specialty since the single-author textbooks referred to above. The unprecedented format of this work lies in its meticulous attention to detail yet comprehensive scope. For example, great detail is seen in manuscripts dealing with topics such as “Exosomes, naturally occurring minimal antigen presenting units” and “Neuropeptide S receptor 1 (NPSR1), an asthma susceptibility gene.” The scope is exemplified by the unique approach to disease entities normally dealt with in a single chapter in most texts. For example, anaphylaxis, a topic usually confined to one chapter in most textbooks, is given five chapters in Allergy Frontiers. This approach allows the text to employ multiple contributors for a single topic, giving the reader the advantage of being introduced to more than one vi- point regarding a single disease. |
| epinastine hydrochloride ophthalmic solution: Ophthalmic Medicines 2005 Physicians Desk Reference, Thomson PDR Staff, Douglas J Rhee, M D, Christopher J Rapuano, M D, Theresa L Belzer, 2004 This volume presents drugs and equipment related to eye care including lensesand lens care, specialized instrumentations and sutures. |
| epinastine hydrochloride ophthalmic solution: Clinical Ocular Pharmacology Jimmy D. Bartlett, Siret D. Jaanus, 2007-11-12 Written by experts in the field, this comprehensive resource offers valuable information on the practical uses of drugs in primary eye care. Discussions of the pharmacology of ocular drugs such as anti-infective agents, anti-glaucoma drugs, and anti-allergy drugs lead to more in-depth information on ocular drugs used to treat a variety of disorders, including diseases of the eyelids, corneal diseases, ocular infections, and glaucoma. The book also covers ocular toxicology, focusing on drug interactions, ocular effects of systemic drugs, and life-threatening systemic emergencies. A logical organization makes it easy to find essential information. Complete coverage of the basic fundamentals of pharmacology such as ocular drug delivery and ocular drug formulations. Comprehensive reviews of the pharmacology of specific classes of agents such as the cycloplegics, antiglaucoma drugs, anti-inflammatory drugs, ocular irrigating solutions, and contact lens care products. In-depth information on ocular drugs used in clinical practice, including chapters on drugs used to treat eyelid disorders, lacrimal diseases, conjunctiva diseases, corneal diseases, allergies, uveitis, postoperative cataract, retinal diseases, and glaucoma. Coverage of ocular toxicology, including drug interactions, ocular effects of systemic drugs, and life-threatening systemic emergencies. Completely revised and updated content that reflects the latest advances in pharmacology. Updated information on post-operative drugs, including LASIK follow up medications. Expanded coverage in the chapters on Anti-infective Drugs, Anti-allergy Drugs and Decongestants, and Lubricants and Other Preparations of Ocular Surface Disease that includes the latest advancements in antibiotics and medications used to treat allergies and dry eye. A dosage quick reference guide on the inside front cover for quick and easy access. Information on the use of herbal medications. |
| epinastine hydrochloride ophthalmic solution: MOVIPREP Drug Profile, 2023 DrugPatentWatch, 2023-08-15 <h2>MOVIPREP Drug Profile, 2023</h2> <p>This report focuses on MOVIPREP and covers the following critical aspects of this drug:</p> <ul><li>United States patents</li> <li>FDA Paragraph IV patent challenges</li> <li>District Court patent litigation</li> <li>European supplementary protection certificates (SPCs)</li> <li>Clinical trials</li> <li>Drug prices</li> <li>Annual sales revenues</li> <li>Finished product suppliers</li> </ul> |
| epinastine hydrochloride ophthalmic solution: Absolute Allergy and Immunology Board Review Massoud Mahmoudi, 2022-10-28 This book offers a comprehensive review of allergy and immunology, specifically dedicated as a board review preparation. The book is a collective effort and participation of over 90 well known allergists, immunologists, and rheumatologist who are academician and or practitioners. Chapters are presented in a Case-Based format. Each chapter presents 2 cases; each case is followed by multiple choice questions/ answers and discussions. Each chapter also offers a list of specific references used in the text, that will enhance the readers' portfolio of resources. Allergy and Immunology Board Review is a must-have resource for allergy & immunology fellows-in-training and all allergy practitioners as well as any medical provider including residents, medical students and allied health who rotate in allergy divisions. |
| epinastine hydrochloride ophthalmic solution: Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 29th Edition (2009) Food and Drug Administration, 2009 FDA Orange Book 29th Edition - 2009 (Approved Drug Products With Therapeutic Equivalence Evaluations) |
| epinastine hydrochloride ophthalmic solution: Ocular Therapeutics Thomas Yorio, Abbott Clark, Martin B Wax, 2011-04-28 Ocular Therapeutics: Eye on New Discovery focuses on emerging areas in ocular research, from new approaches to dry eye to gene therapy in the management of retinal diseases. This comprehensive book features more than 25 chapters of information that will be vital for ocular investigators and ophthalmologists bringing them new information on promising therapeutics. It is the intent of this book to provide not only information on current approaches to treatment, but also in giving the reader a greater understanding as to what may become available for treating a number of important eye diseases. Each chapter features some new aspect of treatment that holds great promise for the future. The approach has been to concentrate on those areas of ocular diseases that are more prevalent. It also features new insight for drug delivery and for managing devasting diseases, such as macula edema and glaucoma, two of the leading causes of blindness in the United States. This book will serve as an important resource as it contains a number of relevant references highlighted for their importance to the field. New investigators will be able to obtain an historical perspective for each of the topics and to develop an understanding of the new research directions that are underway. Ocular Therapeutics: Eye on New Discovery is more than a reference book, as it also provides an important glimpse into the near future.* Contains information that is vital for ocular investigators and ophthalmologists bringing them new information on promising therapeutics.* Provides not only information on current approaches to treatment, but also gives the reader a greater understanding as to what may become available for treating a number of important eye diseases.* Historical perspective for each of the topics as well as an important glimpse into the near future to develop an understanding of the new research directions underway.* New insight for drug delivery and for managing devastating diseases, such as macula edema and glaucoma, two of the leading causes of blindness in the United States |
| epinastine hydrochloride ophthalmic solution: An Eye on Numbers: A Ready Reckoner in Ophthalmology Anand Shroff, 2011 |
| epinastine hydrochloride ophthalmic solution: Modell's Drugs in Current Use and New Drugs, 2006 Milagros Fernandez, PharmD, Lydia Calix, BS, Pharm, RPh, 2006-02-08 Now in its fifty-second year, this annually updated drug reference provides succinct information on the new drugs of this year and on medications in current use. It offers a concise and portable alternative to the ìmegaî drug reference volumes available elsewhere. The compact format contains essential information on nearly 1,100 generic drugs, with cross references to over 1,200 trade names. Highlights include a glossary listing the common side effects of the drugs. Special attention is given to the new drugs with expanded patient care implications for nurses and other allied health professionals. |
| epinastine hydrochloride ophthalmic solution: Nursing2015 Drug Handbook Lippincott, 2014-04-16 The 35th edition of the best-selling, original drug handbook for nurses provides complete monographs for more than 900 generic and thousands of brand-name drugs. Monographs are consistently formatted for ease of use and focus on the practical information that nurses need. Each monograph consists of generic and trade names, pronunciation key, pregnancy risk category, pharmacologic class, controlled substance schedule (if applicable), available forms, indications and dosages, administration (with drug incompatibities for I.V. drugs), action (including tables showing route, onset, peak, duration, and half-life), adverse reactions, interactions, effects on lab test results, contraindications, nursing considerations, and patient teaching. Also includes chapters on general drug information (pharmacology/pharmacotherapeutics, pharmacogenomics, safe drug administration, therapeutic classifications) and numerous appendices. Text is complemented by free Toolkit containing hundreds of online resources. You can also count on Nursing2015 Drug Handbook to tell you unapproved, off-label drug uses so you’ll always know why a drug is prescribed. And, this year, be a more confident nurse with fingertip access to ... • 24 NEW FDA-approved drugs • NEW! Safety information: Preventing and treating extravasation, Preventing exposure to hazardous drugs • NEW! Indication & Dosage Appendices--Nutritional supplements, Antacids, Laxatives • NEW coverage of pharmacogenomics. With the safeguards you’ll find only in the Nursing2015 Drug Handbook, it’s easier than ever to stay current on the 2,821 latest changes to drug information and to avoid even the most common medication errors: • Adjust-a-dose feature for dosage adjustments needed by special populations • Administration guidelines for all appropriate routes • Expanded full-color pill guide containing more drug images than in any previous edition! • Increased coverage of adverse reactions! Includes those that occur with 1% & greater frequency, with special emphasis on life-threatening adverse reactions • Chapters on drug classes, drug safety, drug interactions, and drug therapy across the lifespan • Combination drug section • Elder care medication tips and pediatric drug-error information in appendices • Evidence-based off-label indications and dosages • FDA Black Box Warnings in appropriate drug monographs • Interactions by Drug-drug, Drug-food, Drug-lab tests, Drug-alternative therapy clearly identified • Less Commonly Used Drugs appendix provides essential information, including indications and dosages for very infrequently used drugs • Overdose signs & symptoms, where appropriate • Robust Web Toolkit with hundreds of tools and resources, including monthly drug updates, warnings, and news capsules • Safe Drug Administration chapter focuses on the most current guidelines, ISMP initiatives, and contemporary patient safety issues (such as REMS), preventing and treating extravasation, and preventing exposure to hazardous drugs • Safety alert icon for potentially toxic drugs, I.V. drug incompatibility, dialyzable drugs, toxic drug-drug interactions, and much more. |
Epinastine: Indications, Side Effects, Warnings - Drugs.com
Mar 25, 2024 · Easy-to-read patient leaflet for Epinastine. Includes indications, proper use, special instructions, precautions, and possible side effects. Skip to main content
Epinastine - Wikipedia
Epinastine (brand names Alesion, Elestat, Purivist, Relestat) is a second-generation antihistamine and mast cell stabilizer that is used in eye drops to treat allergic conjunctivitis. It is produced …
Epinastine (Elestat) - Uses, Side Effects, and More - WebMD
Oct 30, 2024 · Overview: Epinastine is an eye drop used to prevent itchy eyes from allergies. The most common side effects of epinastine eye drops are eye burning, itching, and redness; …
Epinastine eye drops: Uses, Tips, Side Effects & More - GoodRx
Oct 17, 2024 · Epinastine hydrochloride is an antihistamine eye drop medication. It's used to prevent eye itchiness that's related to allergies. The eye drops are available by prescription for …
Epinastine - StatPearls - NCBI Bookshelf
Jul 18, 2023 · Epinastine is a mast cell stabilizer as well as an anti-histaminic, which the FDA has approved for topical use to relieve various allergic conditions. Since epinastine does not …
Epinastine (ophthalmic route) - Mayo Clinic
Feb 1, 2025 · Epinastine ophthalmic (eye) solution is used to prevent itching of the eye caused by a condition known as allergic conjunctivitis. It works by preventing the effects of certain …
Epinastine: Side Effects, Uses, Dosage, Interactions, Warnings - RxList
Oct 18, 2023 · Epinastine is a prescription medication used for the prevention of itching associated with allergic conjunctivitis.
Elestat (epinastine) dosing, indications, interactions, adverse …
Medscape - Indication-specific dosing for Elestat (epinastine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost...
Epinastine: Uses, Interactions, Mechanism of Action - DrugBank …
Epinastine is an antihistamine and an inhibitor of histamine release from the mast cell for topical administration to the eyes. Epinastine is indicated for the prevention of itching associated with …
PATIENT & CAREGIVER EDUCATION Epinastine
What is this drug used for? It is used to treat eye irritation due to allergies. What do I need to tell my doctor BEFORE I take this drug? If you are allergic to this drug; any part of this drug; or …
Epinastine: Indications, Side Effects, Warnings - Drugs.com
Mar 25, 2024 · Easy-to-read patient leaflet for Epinastine. Includes indications, proper use, special instructions, precautions, and possible side effects. Skip to main content
Epinastine - Wikipedia
Epinastine (brand names Alesion, Elestat, Purivist, Relestat) is a second-generation antihistamine and mast cell stabilizer that is used in eye drops to treat allergic conjunctivitis. It is produced …
Epinastine (Elestat) - Uses, Side Effects, and More - WebMD
Oct 30, 2024 · Overview: Epinastine is an eye drop used to prevent itchy eyes from allergies. The most common side effects of epinastine eye drops are eye burning, itching, and redness; …
Epinastine eye drops: Uses, Tips, Side Effects & More - GoodRx
Oct 17, 2024 · Epinastine hydrochloride is an antihistamine eye drop medication. It's used to prevent eye itchiness that's related to allergies. The eye drops are available by prescription for …
Epinastine - StatPearls - NCBI Bookshelf
Jul 18, 2023 · Epinastine is a mast cell stabilizer as well as an anti-histaminic, which the FDA has approved for topical use to relieve various allergic conditions. Since epinastine does not …
Epinastine (ophthalmic route) - Mayo Clinic
Feb 1, 2025 · Epinastine ophthalmic (eye) solution is used to prevent itching of the eye caused by a condition known as allergic conjunctivitis. It works by preventing the effects of certain …
Epinastine: Side Effects, Uses, Dosage, Interactions, Warnings - RxList
Oct 18, 2023 · Epinastine is a prescription medication used for the prevention of itching associated with allergic conjunctivitis.
Elestat (epinastine) dosing, indications, interactions, adverse …
Medscape - Indication-specific dosing for Elestat (epinastine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost...
Epinastine: Uses, Interactions, Mechanism of Action - DrugBank …
Epinastine is an antihistamine and an inhibitor of histamine release from the mast cell for topical administration to the eyes. Epinastine is indicated for the prevention of itching associated with …
PATIENT & CAREGIVER EDUCATION Epinastine - Memorial …
What is this drug used for? It is used to treat eye irritation due to allergies. What do I need to tell my doctor BEFORE I take this drug? If you are allergic to this drug; any part of this drug; or …
